Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
Countries citing papers authored by Aram V. Chobanian
Since
Specialization
Citations
This map shows the geographic impact of Aram V. Chobanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aram V. Chobanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aram V. Chobanian more than expected).
Fields of papers citing papers by Aram V. Chobanian
This network shows the impact of papers produced by Aram V. Chobanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aram V. Chobanian. The network helps show where Aram V. Chobanian may publish in the future.
Co-authorship network of co-authors of Aram V. Chobanian
This figure shows the co-authorship network connecting the top 25 collaborators of Aram V. Chobanian.
A scholar is included among the top collaborators of Aram V. Chobanian based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Aram V. Chobanian. Aram V. Chobanian is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Chobanian, Aram V., George L. Bakris, Henry R. Black, et al.. (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 42(6). 1206–1252.10256 indexed citations breakdown →
Fröhlich, Edward D., Carl S. Apstein, Aram V. Chobanian, et al.. (1992). The Heart in Hypertension. New England Journal of Medicine. 327(14). 998–1008.584 indexed citations breakdown →
Chobanian, Aram V.. (1987). Introduction. The American Journal of Cardiology. 59(13). F1–F2.7 indexed citations
13.
Chobanian, Aram V., Peter Brecher, & Christian C. Haudenschild. (1986). Effects of Hypertension and of Antihypertensive Therapy on Atherosclerosis State of the Art Lecture. Hypertension. 8(4).8 indexed citations
Chobanian, Aram V., Edward R. Arquilla, Thomas B. Clarkson, et al.. (1982). Cardiovascular Complications. Diabetes. 31(Supplement_1). 54–64.18 indexed citations
Chobanian, Aram V., Ladislav Volicer, Chang‐seng Liang, Glenn R. Kershaw, & Charles P. Tifft. (1977). Use of propranolol in the treatment of idiopathic orthostatic hypotension.. PubMed. 90. 324–34.21 indexed citations
20.
Hollander, William & Aram V. Chobanian. (1959). The effects of an inhibitor of cholesterol biosynthesis triparanol (MER-29), in subjects with and without coronary artery disease.. PubMed. 10(2). 37–44.9 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.